Immunotherapy

• Health & Medicine

New treatment option made available for advanced womb cancers

Dostarlimab (also called Jemperli) has been recommended by the National Institute of Health and Care Excellence (NICE) to treat some types of advanced or recurrent womb cancer Dostarlimab (also called Jemperli) has been recommended by the National Institute of Health and Care Excellence (NICE) to treat some types of advanced or recurrent womb cancer

8 March 2024

• Science & Technology

The secret in cancer cells that can make immunotherapy more effective

Our researchers have found mutations that make cancers much more likely to respond to immunotherapy. It's a chance to make breakthrough treatments work for many more people. Our researchers have found mutations that make cancers much more likely to respond to immunotherapy. It's a chance to make breakthrough treatments work for many more people.

31 January 2024

• For Supporters

Immunotherapy: puzzles and promise

Immunotherapy is a new type of treatment causing a buzz in the medical community. But what makes it so exciting? Immunotherapy is a new type of treatment causing a buzz in the medical community. But what makes it so exciting?

25 January 2024

• Science & Technology
• Health & Medicine

2023 roundup: 5 of our most important cancer research stories of the year

2023 has been a big year for Cancer Research UK, and there's been a lot to celebrate. So, to end the year, we want to highlight just a few of our most exciting research stories of 2023. 2023 has been a big year for Cancer Research UK, and there's been a lot to celebrate. So, to end the year, we want to highlight just a few of our most exciting research stories of 2023.

18 December 2023

• Health & Medicine

Durvalumab immunotherapy recommended for advanced bile duct cancers in England and Scotland

The immunotherapy durvalumab (Imfinzi) is now available as a first treatment for advanced biliary tract cancers in England and Scotland. The immunotherapy durvalumab (Imfinzi) is now available as a first treatment for advanced biliary tract cancers in England and Scotland.

30 November 2023

• Health & Medicine

First immunotherapy approved for cervical cancer in England and Scotland

The immunotherapy pembrolizumab may help some people with incurable cervical cancer live longer. It's now an approved treatment for them in England and Scotland. The immunotherapy pembrolizumab may help some people with incurable cervical cancer live longer. It's now an approved treatment for them in England and Scotland.

16 May 2023

• Health & Medicine

Children’s cancer charities team up for tomorrow’s treatments

We're helping treble funding for paediatric Experimental Cancer Medicine Centres, paving the way to more effective and less toxic treatments for children and young people. We're helping treble funding for paediatric Experimental Cancer Medicine Centres, paving the way to more effective and less toxic treatments for children and young people.

3 April 2023

• Science & Technology
• Health & Medicine

Cancer vaccines – where are we?

Cancer vaccine development has had many challenges. But with recent breakthroughs and new partnerships, could we be closer than ever? Cancer vaccine development has had many challenges. But with recent breakthroughs and new partnerships, could we be closer than ever?

24 February 2023

• Science & Technology

Hiding in plain sight: How we can use immune cells to deliver cancer-killing viruses to tumours

Researchers have found a way to deliver cancer-killing viruses to tumours by hiding them inside immune cells. Researchers have found a way to deliver cancer-killing viruses to tumours by hiding them inside immune cells.

9 February 2023

• Health & Medicine

NICE recommends pembrolizumab for 1,600 more people with breast cancer

The "potentially life-saving" immunotherapy drug pembrolizumab is now recommended for some people with early triple negative breast cancer in England and Wales. The "potentially life-saving" immunotherapy drug pembrolizumab is now recommended for some people with early triple negative breast cancer in England and Wales.

14 November 2022

• Health & Medicine
• Science & Technology

Repurposing radiotherapy drugs could give immunotherapy a boost

Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs

11 November 2022

• For Researchers

A new approach to cancer immunotherapy

Forty years ago, hints of a new component of the immune system caused a stir. Here, we chart the story of gamma delta T cells from discovery to clinical trials... Forty years ago, hints of a new component of the immune system caused a stir. Here, we chart the story of gamma delta T cells from discovery to clinical trials...

18 March 2022